SK
Syamala K
Active Director Director DIN 11877982
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value •••• Premium profile
About Syamala K
Syamala K is a Director at Novaire Pharma Private Limited (since 2026).
DIN 11877982
Primary Designation Director
First Appointment 07 Aug 2026
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novaire Pharma Private Limited U46497KL2026PTC105428 | Director | 07 Aug 2026 | 2026 | Active |
Board colleagues of Syamala K
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hepsibai | 11877983 | Novaire Pharma Private Limited | Director/Designated Partner |
| Anikuttan Wilson Hepsibai | Novaire Pharma Private Limited | Individual Subscriber | |
| Moothar Veettil Akash | Novaire Pharma Private Limited | Individual Subscriber |
Directorship timeline
Open interactive timeline →Novaire Pharma Private Limited
Premium access
Shareholding and investment profile for Syamala K
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syamala K
Syamala K currently holds 1 directorship: Novaire Pharma Private Limited (Director, since 07 Aug 2026).
Syamala K was first appointed on 07 Aug 2026 as Director at Novaire Pharma Private Limited.
The current boards of Syamala K's companies include Hepsibai (Novaire Pharma Private Limited), Anikuttan Wilson Hepsibai (Novaire Pharma Private Limited), Moothar Veettil Akash (Novaire Pharma Private Limited).